PCB:NASDAQPCB Bancorp Analysis
Data as of 2026-06-04 - not real-time
$24.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
PCB Bancorp trades around $24, sitting just above its 20‑day SMA (≈24.29) which remains above the 50‑day (23.91) and 200‑day (22.38) averages, signaling a bullish alignment despite a bearish MACD histogram and a neutral RSI near 46. The stock is hovering near its technical support at 23.26 with resistance at 25.15, while volume has been on a decreasing trend, suggesting a cautious market participation. Its beta of 0.52 points to low market‑price sensitivity, though 30‑day volatility of roughly 22.7% indicates moderate price swings.
Fundamentally, PCB appears deeply undervalued: a trailing P/E of 8.6 versus an industry average of 16.4, price‑to‑book near parity at 1.04, and a dividend yield of 3.5% with a modest payout ratio under 30%. Strong profitability metrics—operating margin above 50% and ROE around 10.5%—combined with a solid cash position (~$267 M) against relatively low debt (~$68 M) underpin the valuation case. The DCF‑derived fair value of roughly $74 suggests significant upside, while analyst targets sit near $26, and the market sentiment index reflects “Extreme Greed,” hinting at bullish investor appetite.
Fundamentally, PCB appears deeply undervalued: a trailing P/E of 8.6 versus an industry average of 16.4, price‑to‑book near parity at 1.04, and a dividend yield of 3.5% with a modest payout ratio under 30%. Strong profitability metrics—operating margin above 50% and ROE around 10.5%—combined with a solid cash position (~$267 M) against relatively low debt (~$68 M) underpin the valuation case. The DCF‑derived fair value of roughly $74 suggests significant upside, while analyst targets sit near $26, and the market sentiment index reflects “Extreme Greed,” hinting at bullish investor appetite.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bullish SMA hierarchy
- Neutral momentum (RSI ~46) and bearish MACD histogram
- Attractive dividend yield of 3.5% with low payout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to peers (P/E 8.6 vs industry 16.4)
- Strong profitability and low leverage
- Potential price appreciation toward resistance and analyst target around $26
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value indicating substantial upside
- Sustainable dividend and solid balance sheet
- Low beta and consistent earnings growth supporting long‑term stability
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin34.76%
P/E Ratio8.6
ROE10.52%
ROA1.23%
P/B Ratio1.0
Op. Cash Flow$44.9M
Industry P/E16.4
Technical Analysis
TrendBullish
RSI46.9
Support$23.26
Resistance$25.15
MA 20$24.29
MA 50$23.91
MA 200$22.38
MACDBearish
VolumeDecreasing
Fear & Greed Index91.73
Valuation
Fair Value$74.32
Target Price$26.00
Upside/Downside8.33%
GradeUndervalued
TypeValue
Dividend Yield3.50%
Risk Assessment
Beta0.81
Volatility22.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.